Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are male or female and aged 18 or older.
- Women who either test negative for pregnancy and are not breastfeeding, or who are not able to become pregnant (for example, due to menopause for at least 2 years, a hysterectomy, or bilateral tubal ligation).
- Women who are able to become pregnant must have been using a reliable form of contraception (such as hormonal contraceptives, an IUD, spermicide with barrier, or have a partner who has had a vasectomy) for at least 1 month before joining, and must agree to continue using it throughout the study — or must be abstinent and agree to remain so or begin contraception if sexual activity begins.
- People who have a confirmed colorectal condition that requires surgery, with a plan to use robotic surgical techniques.
- For robotic procedures performed through the anal canal, people whose condition meets standard medical guidelines for this type of surgery — including early-stage rectal cancer (T1N0), pre-cancerous growths, or localised neuroendocrine tumours located within 15 cm of the anal opening.
- People who are in good general health based on their medical history and a physical examination.
- People who are willing and able to sign a written consent form.
- People who agree to follow the study requirements and complete all study-related tasks.
- People who have a stable home address and access to a telephone.
Who may not be able to join:
- People under 18 years of age.
- Women who are pregnant or currently breastfeeding.
- People classified as American Society of Anesthesiology (ASA) Class IV — meaning they have a severe ongoing medical condition that is a constant threat to life (confirm with trial site).
- People classified as ASA Class V — meaning they are critically ill and not expected to survive without surgery (confirm with trial site).
- People with a significant history of kidney, liver, neurological, heart, or chronic lung disease that the trial doctor believes would make participation unsafe.
- People with advanced (Stage IV) cancer.
- People who have already received chemotherapy or radiation therapy before surgery (known as neo-adjuvant treatment).
- People who require emergency surgery.
- People who are not able to fully understand or agree to the study requirements.
- People who are not willing or able to attend follow-up visits after surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ankit Sarin, MD, University of California, Davis
Phone: 9167034472
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess safety & quality event rate for SP platform transabdominal and transanal colorectal operations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.